BEHRING COAGULATION SYSTEM (BCS)— 510(k) K000973

Substantially Equivalent

Dade Behring, Inc.

FDA 510(k) clearance K000973 for BEHRING COAGULATION SYSTEM (BCS), Substantially Equivalent on 2000-05-26. Applicant: Dade Behring, Inc..

Clearance details

Applicant: Dade Behring, Inc.
Product code: Code JPA
Advisory panel: Hematology
Date received: 2000-03-27
Decision date: 2000-05-26
Decision: Substantially Equivalent
Clearance type: Traditional
Location: P.O. Box 6101, Newark, DE, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code JPA

product code JPA

Death: 6
Total: 6

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.